Personalis, Inc.

NASDAQ:PSNL

Medical - Diagnostics & Research

Healthcare
$14.98 +3.44%

+$0.34 today

Market cap
$1.62B
Beta
2.28
P/E (TTM)
-11.0
EPS (TTM)
-$0.92
52W Low $3.84High $12.53

Volume 1.47M

Average 2.31M

PSNL Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Personalis, Inc.NASDAQ: PSNL

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 1.8%

Gross margin was 1.8% in Q1 FY2026, down 33.2 pp from a year earlier. On a trailing-twelve-month basis it was 13.7%, down 19.6 pp year over year.

Context

  • Gross margin widened in 2 of the last 2 fiscal years.
  • FY2024 was the highest level in the 3 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
1.8%-9.1 pp QoQ
Last fiscal yearDec 2025
—— YoY
LTMMar 2026
13.7%-19.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-33.2 pp——
1 year———
3 years———
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2024
31.7%
Year-over-year change
+6.9pp

Gross Margin vs competitors

How PSNL compares with its peers on the latest reported figures

  • PSNL's LTM Mar 2026 gross margin of 13.7% is the 9th highest of the 10 companies compared; the peer median is 65.3%.
  • Its year-over-year change of -19.6 pp is the lowest of 10, against a peer median of +1.4 pp.
PSNL Competitors Peer median
Gross Margin for PSNL and competitors
Company Period LTM level YoY 3-year change
VCYTVeracyte, Inc.LTM Jun 202672.1% +3.8 pp+3.9 pp
BLLNBillionToOne, Inc.LTM Jun 202671.3% +10.3 pp—
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
WGSGeneDx Holdings Corp.LTM Jun 202668.2% +1.0 pp+81.1 pp
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
FLGTFulgent Genetics, Inc.LTM Mar 202638.7% -0.1 pp-18.7 pp
PSNLPersonalis, Inc.LTM Mar 202613.7% -19.6 pp—
GRALGRAIL, Inc.LTM Jun 2026-10.8% +45.7 pp+167.1 pp
Peer median (excluding PSNL) 65.3%+1.4 pp+2.9 pp

Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue85.49M65.05M73.48M84.61M0
Cost of Revenue53.84M51.7M55.27M57.79M53.87M
Gross Profit31.66M13.35M18.21M26.83M(53.87M)
Gross Margin37.0%20.5%24.8%31.7%—
Research & Development49.31M64.91M64.78M48.91M50.26M
Selling, General & Admin47.7M63.97M49.73M46.19M53.57M
Operating Expenses97.01M128.88M128.14M95.09M34.19M
Depreciation & Amortization6.01M8.43M11.3M10.94M10.05M
EBITDA(59.01M)(104.64M)(96.81M)(70.3M)(71M)
EBITDA Margin-69.0%-160.9%-131.7%-83.1%—
Operating Income(65.35M)(115.53M)(109.94M)(68.27M)(88.06M)
Operating Margin-76.4%-177.6%-149.6%-80.7%—
Interest Income367K2.4M5.9M5.51M7.16M
Interest Expense184K201K110K24K205K
Other Income / Expenses141K2.26M1.72M(13M)6.81M
Income Before Tax(65.21M)(113.28M)(108.21M)(81.27M)(81.25M)
Pre-Tax Margin-76.3%-174.1%-147.3%-96.0%—
Income Tax Expense14K40K83K18K21K
Net Income(65.23M)(113.32M)(108.3M)(81.28M)(81.27M)
Net Margin-76.3%-174.2%-147.4%-96.1%—
EPS (Basic)(1.49)(2.48)(2.25)(1.37)(0.91)
EPS (Diluted)(1.49)(2.48)(2.25)(1.37)(0.91)
Weighted Avg Shares43.89M45.7M48.18M59.25M89.24M
Weighted Avg Shares (Diluted)43.89M45.7M48.18M59.25M89.24M

Personalis, Inc.

NASDAQ:PSNL

Intrinsic Alpha fair value

Locked

Current Price

$14.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.